Caplyta phase 3 data show rapid, significant mania symptom relief in bipolar I by day 3, sustained to week 3, with tolerable adverse effects.
|Slideshows|October 17, 2018
Screen Time Solutions for Depression and Bipolar Disorder
Author(s)Chris Aiken, MD
Unremitting screen time worsens two systems that are already fragile in people with mood disorders-sleep and circadian rhythms.
Advertisement
Advertisement
Related to this article
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
3
The Top 7 Atypical Psychedelics: A Brief Clinical Guide
4
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
5